Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen Inc. AMGN is Attracting Investor Attention: Here is What You Should Know

December 03, 2024
Amgen Inc. (NASDAQ:AMGN) has been making waves in the investment world with its impressive returns and strong potential for growth. With a return on equity (ROE) of 56%, the company is proving to be a lucrative investment option for many.

Amgen's success can be attributed to its innovative and diverse product portfolio. The company has been a leader in the biotechnology industry, developing and commercializing therapeutics for various diseases and conditions. Its flagship drugs, Repatha and Prolia, have been driving revenues and boosting earnings.

Repatha, a cholesterol-lowering drug, has been particularly successful in the market. The drug has shown significant efficacy in reducing cardiovascular events in patients with high cholesterol levels. As a result, Repatha has become a go-to option for many physicians and patients alike.

Prolia, on the other hand, is Amgen's bone-building drug that targets osteoporosis and other bone disorders. The drug has gained popularity due to its ability to reduce fracture risk and improve bone health in postmenopausal women.

Amgen's strong financial performance has attracted the attention of investors. The company's stock price has shown resilience even during challenging market conditions. However, it's important to note that investing in stocks involves risks, and it's advisable to seek professional advice before making any investment decisions.

If you are considering investing in Amgen, it is recommended to consult with professionals from Stocks Prognosis. Their expertise and in-depth analysis of market trends can provide valuable insights and assist in making informed investment choices. Keep an eye on Amgen as it continues to shine in the biotech industry with its innovative products and promising pipeline.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNJuly 30, 2025Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve  ~1 min.

Recently, Representative Jefferson Shreve unloaded a significant number of Amgen Inc. (NASDAQ:AMGN) shares....


AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....


AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....


AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....


AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....


AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....


AMGNMarch 10, 2025AMGEN INC. Hits Price Target Forecast with 20.7% Profit: A Success Story for QuantWave  ~1 min.

AMGEN INC. has recently reached the price target forecast set by QuantWave, resulting in a significant profit of 20.7% for investors who followed the predictive signal....


AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....


AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....


AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....


AMGNDecember 15, 2024Amgen Inc. Announces Strong Q2 Earnings: Here's What You Need to Know  ~2 min.

Amgen Inc., a leading biotechnology company, has reported strong financial results for the second quarter of 2025. The company's revenue reached a record high of $7....


AMGNDecember 28, 2024Amgen Inc.'s Stock Shows Promising Gains: Here's the Latest Update  ~2 min.

Investors are eagerly searching for information on Amgen Inc. (NASDAQ:AMGN) as the company's stock gains momentum in the market....


AMGNDecember 20, 2024Amgen Inc. AMGN: A Promising Dividend Stock with Favorable Returns  ~2 min.

Investors of Amgen Inc. (NASDAQ:AMGN) have enjoyed a favorable return of 34% over the past three years, making it one of the best dividend stocks to invest in....


AMGNDecember 26, 2024Amgen Inc. Continues to Attract Investors: Promising Outlook for AMGN  ~2 min.

Leading biotechnology company Amgen Inc. (NASDAQ:AMGN) has caught the attention of investors with its solid performance and positive market trends. In recent news, Principal Financial Group Inc....


AMGNNovember 10, 2024Consolidated Planning Corp Buys 1842 Shares of Amgen Inc. NASDAQ:AMGN  ~2 min.

Consolidated Planning Corp, a prominent investment firm, has recently acquired 1842 shares of the pharmaceutical giant Amgen Inc. NASDAQ:AMGN....